Dr Ru Dee Ting

Honorary Associate
Medicine, Sydney Medical School
NHMRC Clinical Trials Centre

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Ting, R., Keech, A. (2013). Fenofibrate and renal disease: Clinical effects in diabetes. Clinical Lipidology, 8(6), 669-680. [More Information]
  • Hankey, G., Anderson, N., Ting, R., Veillard, A., Romo, M., Wosik, M., Sullivan, D., O'Connell, R., Hunt, D., Keech, A. (2013). Rates and predictors of risk of stroke and its subtypes in diabetes: A prospective observational study. Journal of Neurology, Neurosurgery and Psychiatry, 84(3), 281-287. [More Information]
  • Ting, R., Keech, A., Drury, P., Donoghoe, M., Hedley, J., Jenkins, A., Davis, T., Lehto, S., Celermajer, D., Simes, R., Rajamani, K., et al (2012). Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment - The FIELD Study. Diabetes Care, 35(2), 218-225. [More Information]
  • Davis, T., Ting, R., Best, J., Donoghoe, M., Drury, P., Sullivan, D., Jenkins, A., O'Connell, R., Whiting, M., Glasziou, P., Simes, R., Gebski, V., Keech, A., et al (2011). Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia: clinical and experimental diabetes and metabolism, 54(2), 280-290. [More Information]
  • Drury, P., Ting, R., Zannino, D., Ehnholm, C., Flack, J., Whiting, M., Fassett, R., Ansquer, J., Dixon, P., Davis, T., Pardy, C., Keech, A., et al (2011). Estimated Glomerular Filtration Rate and Albuminuria are Independent Predictors of Cardiovascular Events and Death in Type 2 Diabetes Mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia: clinical and experimental diabetes and metabolism, 54(1), 32-43. [More Information]
  • Davis, T., Ting, R., Best, J., Donoghoe, M., Drury, P., Sullivan, D., Jenkins, A., O'Connell, R., Whiting, M., Glasziou, P., Simes, R., Gebski, V., Keech, A., et al (2010). Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia: clinical and experimental diabetes and metabolism, 54(2), 280-290. [More Information]

2013

  • Ting, R., Keech, A. (2013). Fenofibrate and renal disease: Clinical effects in diabetes. Clinical Lipidology, 8(6), 669-680. [More Information]
  • Hankey, G., Anderson, N., Ting, R., Veillard, A., Romo, M., Wosik, M., Sullivan, D., O'Connell, R., Hunt, D., Keech, A. (2013). Rates and predictors of risk of stroke and its subtypes in diabetes: A prospective observational study. Journal of Neurology, Neurosurgery and Psychiatry, 84(3), 281-287. [More Information]

2012

  • Ting, R., Keech, A., Drury, P., Donoghoe, M., Hedley, J., Jenkins, A., Davis, T., Lehto, S., Celermajer, D., Simes, R., Rajamani, K., et al (2012). Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment - The FIELD Study. Diabetes Care, 35(2), 218-225. [More Information]

2011

  • Davis, T., Ting, R., Best, J., Donoghoe, M., Drury, P., Sullivan, D., Jenkins, A., O'Connell, R., Whiting, M., Glasziou, P., Simes, R., Gebski, V., Keech, A., et al (2011). Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia: clinical and experimental diabetes and metabolism, 54(2), 280-290. [More Information]
  • Drury, P., Ting, R., Zannino, D., Ehnholm, C., Flack, J., Whiting, M., Fassett, R., Ansquer, J., Dixon, P., Davis, T., Pardy, C., Keech, A., et al (2011). Estimated Glomerular Filtration Rate and Albuminuria are Independent Predictors of Cardiovascular Events and Death in Type 2 Diabetes Mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia: clinical and experimental diabetes and metabolism, 54(1), 32-43. [More Information]

2010

  • Davis, T., Ting, R., Best, J., Donoghoe, M., Drury, P., Sullivan, D., Jenkins, A., O'Connell, R., Whiting, M., Glasziou, P., Simes, R., Gebski, V., Keech, A., et al (2010). Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia: clinical and experimental diabetes and metabolism, 54(2), 280-290. [More Information]

To update your profile click here. For support on your academic profile contact .